-- The global Electronic Drug Delivery Systems (EDDS) market size is expected to reach USD 21.79 Billion in 2032 and is expected to register a steady revenue CAGR of 7.9% during the forecast period, according to latest analysis by Emergen Research.
A rapidly expanding sector of the healthcare market, electronic drug delivery systems use technology to deliver medications to patients precisely and effectively. Inhalation, injection, and transdermal distribution are just a few of the ways that medications can be administered directly into the patient's body using electronic drug delivery systems. These systems are well-liked by both patients and healthcare professionals because they give patients precise dose, increased efficacy, and fewer adverse effects.
In the upcoming years, the market for electronic medication delivery systems is expected to expand significantly, propelled by a number of important factors. The rising incidence of chronic diseases like diabetes, cancer, and respiratory illnesses, which require long-term pharmaceutical treatment, is one of the main factors driving market expansion. By giving patients a more practical and efficient way to manage their drugs, electronic drug delivery systems improve patient outcomes and lower healthcare costs.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1788
The accelerated development of technology in the healthcare sector is another significant element fueling market expansion. Electronic medication delivery systems are growing more complex, adding features like Bluetooth integration, wireless networking, and real-time monitoring capabilities. In the upcoming years, it is anticipated that these developments will increase demand for electronic drug delivery systems as patients and healthcare professionals look for more sophisticated and practical ways to administer medications.
Despite the numerous factors supporting market expansion, there are a number of significant obstacles and constraints that must be taken into account. The price of these devices is one of the biggest issues the market for electronic medicine delivery systems is experiencing. Electronic medication delivery systems can assist patients and healthcare providers greatly, however some individuals and healthcare systems may not be able to afford these expensive gadgets. In developing nations or areas with few healthcare resources, this may restrict the acceptance and usage of these devices.
Electronic Drug Delivery Systems Market Segmentation:
The global electronic drug delivery systems market has been segmented by Emergen Research on the basis of type, application, distribution channel, and region. The type segment includes wearable infusion pumps, auto injectors, injection pens, and inhalers. Wearable infusion pumps are expected to dominate the market due to their ease of use and growing demand for personalized healthcare solutions. Auto injectors and injection pens are also expected to witness significant growth during the forecast period due to their advantages such as accurate dosing and convenience.
In terms of application, the market has been segmented into diabetes, cardiovascular disease (CVD), respiratory disorders, multiple sclerosis, and others. The diabetes segment is expected to witness the fastest revenue growth rate due to the rising prevalence of diabetes and the development of advanced EDDS devices for diabetes management. The respiratory disorders segment is also expected to witness significant growth due to the increasing incidence of respiratory diseases.
The distribution channel segment includes hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to dominate the market due to the high demand for EDDS devices in hospitals and the presence of well-established healthcare infrastructure. Retail pharmacies and online pharmacies are also expected to witness significant growth during the forecast period due to the increasing availability and accessibility of EDDS devices through these channels.
Geographically, the global electronic drug delivery systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market due to the presence of key market players, the increasing prevalence of chronic diseases, and favorable government initiatives. Europe and Asia Pacific are also expected to witness significant growth due to the increasing adoption of advanced healthcare technologies and rising awareness about EDDS devices in these regions.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/electronic-drug-delivery-systems-market
Some Key Highlights From the Report
On 13 April 2022, Halozyme Therapeutics, Inc. and Antares Pharma, Inc., Halozyme will acquire Antares for USD 5.60 per share in cash due to On 13 April 2022, Halozyme Therapeutics, Inc. announced that it will be acquiring Antares Pharma, Inc. for USD 5.60 per share in cash. This acquisition is expected to provide significant benefits to both companies, allowing them to leverage their respective strengths and capabilities to drive growth and innovation in the pharmaceutical industry.
The wearable infusion pumps segment is expected to account for largest revenue share in the EDDS market during the forecast period due to The wearable infusion pumps segment is expected to dominate the revenue share in the Electronic Drug Delivery Systems (EDDS) market during the forecast period. This is due to the increasing prevalence of chronic diseases, the convenience and ease of use of wearable pumps, and the growing demand for more personalized and patient-centric healthcare solutions. Additionally, technological advancements in wearable pumps are expected to further drive market growth.
The diabetes segment is expected to account for fastest revenue growth rate in the global EDDS market during the forecast period due to The diabetes segment is expected to witness the fastest revenue growth rate in the global Electronic Drug Delivery Systems (EDDS) market during the forecast period. This is attributed to the rising prevalence of diabetes globally, the increasing demand for better diabetes management solutions, and the development of advanced EDDS devices for diabetes treatment. The use of EDDS devices for insulin delivery in diabetic patients provides more precise dosing and improved therapy management, which is expected to drive the growth of this segment.
The North America market is expected to account for largest revenue share in the global EDDS market during the forecast period due to The North America market is expected to account for the largest revenue share in the global Electronic Drug Delivery Systems (EDDS) market during the forecast period. This is due to the presence of key market players, the increasing prevalence of chronic diseases, and the rising adoption of advanced healthcare technologies in the region. Additionally, favorable government initiatives and the presence of well-established healthcare infrastructure are expected to drive market growth in North America.
Some major companies in the global market report include Bayer AG, Gerresheimer AG, Medtronic, Elcam Medical, Novo Nordisk A/S, Insulet Corporation, BD, Sanofi, Frederick Furness Publishing, and United Therapeutics Corporation.
About the company: Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Info:
Name: Eric Lee
Email: Send Email
Organization: Emergen Research
Address: 14671 110 Avenue, Surrey, British Columbia, V3R2A9
Phone: 604757975
Website: https://www.emergenresearch.com/
Release ID: 89095059
Google
RSS